-

The Law Offices of Frank R. Cruz Announces Investigation of The Toronto-Dominion Bank (TD) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of The Toronto-Dominion Bank (“TD” or the “Company”) (NYSE: TD) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On October 10, 2024, news outlets reported that TD had plead guilty to criminal money-laundering-related charges and agreed to pay more than $3 billion in fines to the U.S. Department of Justice, the Federal Reserve, the Comptroller of the Currency, and the Treasury Department’s Financial Crimes Enforcement Network. News outlets further reported the Comptroller of the Currency imposed an “asset cap” which limits the Company’s growth until it complies with remedial actions specified by regulators.

On this news, TD’s stock price fell $6.50, or 10.5%, over two consecutive trading days, to close at $57.01 per share on October 11, 2024, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased TD securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

The Law Offices of Frank R. Cruz

NYSE:TD

Release Versions

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

More News From The Law Offices of Frank R. Cruz

Lost Money on Merck & Co., Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 1.76% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--Merck & Co., Inc. ("Merck" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Merck & Co., Inc. (NYSE: MRK), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Merck & Co., Inc. on October 22, 2026. If you lost money on...

Lost Money on Everest Group, Ltd. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 11.4% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--Everest Group, Ltd. ("Everest" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Everest Group, Ltd. (NYSE: EG), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Everest Group, Ltd. on October 27, 2025.If you lost money on Everes...

Lost Money on Tenax Therapeutics, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 89.77% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--Tenax Therapeutics, Inc. ("Tenax" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Tenax Therapeutics, Inc. (NASDAQ: TENX), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Tenax Therapeutics, Inc. on August 10, 2026.If you lost...
Back to Newsroom